We also examined the relationship between occurrence of oxidative stress in our experimental model and PARP-1 activation as a potential mechanism for the manifestation of dyslipidemia-associated vascular and autonomic nervous system dysfunction. Here, PARP1 is linked to metabolic syndrome.